A widespread recall of medical cannabis vaping products in the US state of Pennsylvania has given rise to questions about the role flavour additives play in product safety and has left patients with more questions than answers.
The Pennsylvania Department of Health (DOH) Office for Medical Marijuana issued the recall in February, questioning the safety of 670 products. A local newspaper estimated the recall to affect $12m worth of products, though the paper did not explain how it reached that figure.
...
Need help?
Contact a sales representative right now and don’t wait
“ Pennsylvania medical cannabis vape recall linked to added flavours? ”
Buy report request information:
“ Pennsylvania medical cannabis vape recall linked to added flavours? ”
A widespread recall of medical cannabis vaping products in the US state of Pennsylvania has given rise to questions about the role flavour additives play in product safety and has left patients with more questions than answers.
The Pennsylvania Department of Health (DOH) Office for Medical Marijuana issued the recall in February, questioning the safety of 670 products. A local newspaper estimated the recall to affect $12m worth of products, though the paper did not explain how it reached that figure.
Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Benefits of subscription plans:
Stay informed of any legal and market change in the sector that impacts your organization
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organization
Need help?
Contact a sales representative right now and don’t wait
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.
LATEST ALERTS
